The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 29th 2025
FluMist Home, the first at-home nasal spray flu vaccine, is now available for direct delivery to patients in 34 US states.
Pharmacy Development Services (PDS), the leading provider of business education for independent pharmacy owners, has announced the ten recipients of the 2015 PDS Conference Showcase of Success. For the past nine years, the Showcase of Success segment has been an integral part of the annual business growth conference as a way to demonstrate the opportunities for real results in the industry.
Read More
Pharmacy Times today announced a strategic collaboration with the Pharmacy Podcast Show to strengthen dialogue and spur innovation around key topics regarding the pharmacy profession, health care, and pharmacy business. Pharmacy Podcast creator and host Todd S. Eury will work with Pharmacy Times to create future content and episodes of the podcast that will be integrated into the blog section of the Pharmacy Times website.
Read More
Adverse Reactions to Methylphenidate ADHD Treatment Aren't Serious
February 8th 2015Although children with attention deficit hyperactivity disorder often experience decreased appetite and sleep disturbances during methylphenidate treatment, a study published in the Journal of Research in Pharmacy Practice indicates that those adverse drug reactions (ADRs) are mostly mild and not serious.
Read More
"Holes in the Herd" Linked to Measles Spread
February 7th 2015The current measles outbreak across 14 US states indicates that too few individuals are being vaccinated to prevent infections, according to Jason Gallagher, a clinical pharmacy specialist in infectious diseases at Temple University.
Read More
APhA Diabetes Education Program Honored with National Award for Outstanding Live CE Activity
February 6th 2015The American Pharmacists Association is pleased to announce that the association's education team and The Pharmacist & Patient-Centered Diabetes Care Certificate Training Program were honored with the 2015 Award for Outstanding Live CE Activity by the Alliance for Continuing Education in the Health Professions.
Read More
Measles Outbreak Tests Vaccination Requirement
February 6th 2015The 102 measles infections reported to the US Centers for Disease Control and Prevention since December indicate the consequences of low vaccination rates in certain communities, as well as the public health crisis that could occur if patients continue to decline immunizations.
Read More
Chapman University School of Pharmacy Receives Precandidate Accreditation Status
February 6th 2015Chapman University's School of Pharmacy has received precandidate accreditation status by the Accreditation Council for Pharmacy Education-a national agency for the accreditation of professional degree pharmacy programs.
Read More
Pharmacist, Former Mayor Gets Prison Time for Illegally Dispensing Painkillers
February 6th 2015A former mayor of a West Virginia town wasn't in the news for a ribbon-cutting ceremony or participating in a council meeting. Instead, the ex-mayor and registered pharmacist was sentenced to prison for illegally dispensing thousands of prescription pain pills.
Read More
The American Heart Association's Go Red For Women® is asking all Americans to Go Red to raise awareness of heart disease and stroke in women during the 12th annual National Wear Red Day® on Friday, February 6, 2015. The face of heart disease and stroke has changed, and 1 in 3 women will die.
Read More
GPhA Statement Regarding the Announcement that FDA Commissioner Hamburg Will Step Down
February 6th 2015The Generic Pharmaceutical Association and its members applaud the significant progress made by the agency during Commissioner of Food and Drugs Dr. Margaret Hamburg's six years leading the U.S. Food and Drug Administration. Throughout her tenure, Dr. Hamburg has been a tireless advocate for patient safety and a leader in efforts to assure that FDA decisions are guided by scientific principles.
Read More
Humira Biosimilar Shows Promise in Rheumatoid Arthritis Patients
February 6th 2015Amgen has announced positive results of a phase 3 study evaluating its investigational drug, ABP 501, a biosimilar candidate to AbbVie's fully human anti-tumor necrosis factor alpha monoclonal antibody, adalimumab, in patients with moderate-to-severe rheumatoid arthritis.
Read More